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Abstract
Background A key challenge of identifying diseaseassociated genes is analyzing transcriptomic
data in the context of regulatory networks that control cellular processes in order to capture multi-
gene interactions and yield mechanistically interpretable results. One existing category of analysis
techniques identifies groups of related genes using interaction networks, but these gene sets often
comprise tens or hundreds of genes, making experimental follow-up challenging. A more recent
category of methods identifies precise gene targets while incorporating systems-level information,
but these techniques do not determine whether a gene is a driving source of changes in its network,
an important characteristic when looking for potential drug targets.
Results We introduce GeneSurrounder, an analysis method that integrates expression data and
network information in a novel procedure to detect genes that are sources of dysregulation on the
network. The key idea of our method is to score genes based on the evidence that they influence the
dysregulation of their neighbors on the network in a manner that impacts cell function. Applying
GeneSurrounder to real expression data, we show that our method is able to identify biologically
relevant genes, integrate pathway and expression data, and yield more reproducible results across
multiple studies of the same phenotype than competing methods.
Conclusions Together these findings suggest that GeneSurrounder provides a new avenue for
identifying individual genes that can be targeted therapeutically. The key innovation of GeneSur-
rounder is the combination of pathway network information with gene expression data to determine
the degree to which a gene is a source of dysregulation on the network. By prioritizing genes in this
way, our method provides insights into disease mechanisms and suggests diagnostic and therapeutic
targets. Our method can be used to help biologists select among tens or hundreds of genes for fur-
ther validation. The implementation in R is available at github.com/sahildshah1/gene-surrounder
1 Background
The advent of high–throughput transcription profiling technologies has enabled identification of
genes and pathways associated with disease, providing new avenues for precision medicine. A key
challenge is to analyze this data in the context of the regulatory networks that control cellular
processes, while still obtaining insights that can be used to design new diagnostic and therapeutic
interventions. It is thus necessary to develop methods that analyze omic data in the context of the
full network of interactions, while still providing specific, targetable gene-level findings.
∗Corresponding author: rbraun@northwestern.edu
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The most common method for detecting gene-association is via differential expression analysis,
in which each gene is independently tested for significant differences in mean expression between
phenotypes [1]. However, while differential expression analysis can identify specific (and hence
targetable) disease-associated genes, it does not take into consideration the network of molecular
interactions that govern cellular function, limiting the mechanistic insights that can be derived
from the data. As a result, this analysis can miss crucial multi-gene interactions that underlie
complex phenotypes. Since biological systems are complex and expression data is typically noisy,
the multi-gene mechanisms that underlie a disease may be detectable across multiple studies, but
the individual genes contributing to those mechanisms may vary from one study to the next. As a
result, differential expression analysis can exhibit poor agreement between different studies of the
same conditions [2, 3, 4].
Maps of experimentally derived molecular interaction networks contained in pathway databases
and the growth of analysis techniques that infer context-specific interaction networks have en-
abled the development of methods that integrate systems level information with expression data.
KEGG [5], for example, is a well-established pathway database that organizes genes into hundreds of
individual networks corresponding to biological processes. One use of interaction networks has been
to identify groups of related genes underlying a biological mechanism. By incorporating systems-
level information, these pathway analysis techniques can capture multi-gene interactions, yielding
mechanistically interpretable results that are more reliable than single–gene analyses [2, 3, 4]. Path-
way analysis techniques can be broadly grouped into three categories: ‘functional scoring methods’,
‘topology methods’, and ‘active modules tools.’ Functional scoring methods, such as GSEA [6],
identify groups of genes that are enriched for association with the phenotype of interest. Topology
methods, such as SPIA [7] and CePa [8, 9], also identify groups of genes that are enriched for as-
sociation, but augment functional scoring methods with additional information about the network
of interactions between the genes. Active modules tools, such as jActiveModules [10], HotNet [11],
and COSINE [12], attempt to find disease associated subnetworks within pathways. These methods
integrate systems-level information with expression data to identify groups of related genes.
While pathway analysis techniques integrate systems–level information with omic data to pro-
vide functional interpretations of the dataset, the “significant pathways” identified by such analyses
often comprise tens or hundreds of genes, making experimental follow-up challenging. Addition-
ally, boundaries between pathways are often arbitrary, thus potentially neglecting key interactions.
Moreover, many techniques rely on user–settable parameters and ad-hoc heuristics that depend on
network size, limiting their interpretability and reliability [4, 13]. Together, these issues point to
the need for analysis techniques that integrate network and omics data to identify precise gene
targets for follow-up studies.
Early efforts to identify precise gene targets while incorporating systems-level information in-
clude ENDEAVOUR [14] and GeneWanderer [15]. ENDEAVOUR takes in as input various data
sources (such as literature abstracts and protein-protein interactions) and prioritizes genes based on
their similarity to genes known to be involved in the disease. GeneWanderer uses protein-protein
interaction networks and identifies gene targets based on distance to known disease genes on the
network. However, these methods require knowledge of mechanisms known to be associated with
the disease. Later analysis techniques – such as a method that uses the Laplacian kernel [16],
an extension of SPIA [17], and nDGE [18] – addressed this issue and do not require knowledge
of disease associated mechanisms to identify precise gene targets. The first method uses a protein
association network, recomputes distances using the Laplacian kernel, and finds disease genes based
on “neighboring” differential expression. Since the distances are recomputed, the neighbors could
include genes that are not neighbors on the original network. In other words, this method uses
indirect interactions instead of direct interactions, complicating the interpretation. In the exten-
sion of SPIA [17], disease genes are found by propagating changes in expression along the edges
of the individual pathway so that each gene is scored for disease-association according to its own
change in expression combined with the change in expression of its upstream neighbors. Since each
pathway is considered separately and the pathways have artificial (sometimes overlapping) bound-
aries, an individual pathway could exclude genes that are on a global network (i.e. union of the
individual pathways). nDGE takes in as input expression profiles and for a putative disease gene
class conditionally identifies its co-regulated and actively co-regulated neighbors. While powerful,
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each of these is limited in its treatment of the networks. These methods either do not consider
direct interactions between genes on a global network ([16] uses indirect interactions based on the
Laplacian kernel and [17] considers each KEGG pathway separately) or infer interactions based
on correlations (e.g., [18]). Thus due to the limitations of the previously described techniques, an
analysis technique that takes into account direct interactions between genes globally may prove
useful in identifying targets and the effect they have on the network.
Most recently, LEAN [19] was developed to use direct interactions on a global interaction net-
work and find disease genes by scoring the differential expression of “local subnetworks.” LEAN
scores each gene for disease-association according to the enrichment of its immediate neighbors.
Thus, LEAN’s algorithm restricts its focus to a local subnetwork that only considers nearest neigh-
bors. As a result, LEAN only identifies genes based on the changes in expression of a given gene’s
local subnetwork, but can not determine whether that gene is actually the source of changes in its
neighborhood or on the network; an important characteristic when looking for potential targetable
disease genes for use in precision medicine.
The goal of the present work is to combine pathway network information with gene expression
data to determine the degree to which a gene is a source of dysregulation on the network. We
present a novel analysis technique, GeneSurrounder, that takes into account the complex structure
of interaction networks to identify specific disease-associated genes from expression data. The key
idea of our method is to score genes based on the evidence that they influence the dysregulation
of their neighbors on the network in a manner that impacts cell function. In this way, the genes
returned by our method may be considered sources of “disruption” on the network and therefore
candidate targets for therapeutics. We thus seek to identify genes with two defining characteristics:
(i) they appear to influence other genes nearby in the network, as evidenced by strongly correlated
expression with nearby genes; and (ii) their dysregulation is associated with disease, as evidenced by
a pattern of (progressively weaker) differential expression centered about that gene. By finding these
genes, our method identifies candidate genes that are “disruptive” to the mechanisms underlying
a given phenotype and does so without any reliance on user-set parameters or arbitrary pathway
boundaries.
In this manuscript, we describe the GeneSurrounder algorithm and apply it to data from three
independent studies of ovarian cancer to demonstrate its use, evaluate the reproducibility of its
results, and demonstrate the methodological and biological validity of our approach. In order to
evaluate the algorithm, we evaluate its cross-study concordance, i.e., its consistency across different
data sets measuring the same phenotype. We compare the cross-study concordance of GeneSur-
rounder’s results to that of standard differential expression analysis, and find that genes identified
as sources of pathway disruption by GeneSurrounder are more consistently identified across the
various studies than are differentially expressed genes. We also compare our method to LEAN,
and show that genes identified by GeneSurrounder are more consistent across studies than both
LEAN and differential expression analysis. We demonstrate that our method represents an inte-
gration of pathway and expression data to yield results that are not solely driven by either alone
and find that it identifies genes associated with ovarian cancer. Together, these results suggest that
GeneSurrounder reproducibly detects functionally-relevant genes by integrating gene expression
and network data. Our novel analysis approach complements existing gene– and pathway–based
analysis strategies to identify specific genes that control disease–associated pathways, providing a
new strategy for identifying promising therapeutic targets.
2 Methods
Our goal is to identify candidate disease genes by analyzing gene expression data in the context of
interaction networks to discover genes that drive the behavior of pathways associated with disease.
We thus seek to identify genes with two defining characteristics: (i) they appear to influence other
genes nearby in the network, as evidenced by strongly-correlated expression with nearby genes;
and (ii) their dysregulation is associated with disease, as evidenced by a pattern of differential
expression centered about that gene. Since the ‘extent’ of dysregulation of a given gene on a global
gene network is not known a priori, we score the gene separately for every neighborhood size on the
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network (i.e. genes one ‘hop’ away, genes up to two ‘hops’ away, etc) and then return the results for
the highest scoring neighborhood. Genes with significantly high-scoring neighborhoods may then
be prioritized for follow-up experiments.
To this end, the GeneSurrounder method consists of two tests that are run independently of each
other (Figure 1) and then combined, for every neighborhood size on the network. To determine if
the putative disease gene is a “disruptive” candidate disease gene meeting both criteria, the results
for the highest scoring neighborhood are returned. To prioritize genes, our method is applied
exhaustively to each assayed gene in a transcriptomic data set, and the results from each gene’s
highest scoring neighborhood are compared to rank the genes.
The algorithm takes as input gene expression data and a network model of cellular interactions
derived from a pathway database. In order to consider the full scope of a gene’s interactions and
avoid artificially imposed pathway boundaries, we create a global KEGG network by merging the
individual pathways so that the links which are in at least one KEGG pathway will be part of the
new global network (i.e., the graph union of all pathways). We then consider the largest connected
component of the resulting network in our algorithm. Using this global network and gene expression
data, we compute evidence for each of the above criteria as follows.
Does a gene appear to influence its neighbors in the network? Evidence
of “Sphere of Influence”
If a gene is a source of regulatory control or disruption, we may expect to see that its behavior is
correlated with that of its neighbors. The first step, dubbed “Sphere of Influence,” assesses if a
candidate gene i meets this criterion by testing if gene i is more strongly correlated with its network
neighbors than would be expected by chance (Figure 2), compared to a random sample of genes.
The first step, therefore, of the Sphere of Influence procedure is to calculate the Spearman rank
correlation ρij between gene i and every other gene j assayed and on the network. From this set of
correlations, we calculate the observed total (absolute) correlation between gene i and its neighbors
within a neighborhood of radius r,
Ci(r) =
∑
{j:dij≤r}
|ρij | , (1)
where dij indicates the geodesic distance of gene j from gene i on the network.
In order to compute the distribution of total correlation under the null hypothesis that it is drawn
from a random sample of genes, we re-sample with replacement from the set of correlations between
gene i and every other gene j and recompute Equation 1. This procedure effectively redistributes
the gene–gene correlations about the network, enabling a comparison of gene i’s influence in the
true network neighborhood to its influence on a random selection of genes. This step tests the
so–called “competitive null” described in [3]; that is, whether gene i has a greater correlation with
genes in its neighborhood than would be a expected from a random set of genes.
The null distribution of the total absolute correlation for gene i as a function of the neighborhood
radius is computed using 103 re-samplings, and the observed total absolute correlation is compared
to the re-sampled null distribution, yielding a “Sphere of Influence” p–value at each neighborhood
radius for gene i, pSi (r), that quantifies whether i is more correlated with its neighbors than expected
by chance, evidence that it may be an influential gene.
Does the gene’s neighborhood exhibit an association with phenotype?
Evidence of “Decay of Differential Expression”
The previous step tests whether gene i is strongly correlated with its network neighbors, independent
of phenotype. If a gene is a source of disease-associated disruption, we may expect that it and its
neighbors will exhibit differential expression. We thus now turn our attention to whether the gene
and its neighbors also exhibit an association with the phenotype of interest. In particular, if a
gene i is a source of dysregulation that drives the phenotype, we would expect that gene i and its
close neighbors will be differentially expressed, while genes farther away in the network will exhibit
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weaker differential expression. In other words, we expect a pattern of differential expression that
is strongly localized about i and decays as one moves farther from it in the network.
Hence, the second calculation, “Decay of Differential Expression,” tests whether the magnitude
of differential expression of other genes j in the neighborhood is inversely related to the distance
dij of gene j from gene i (Figure 3).
In order to do this, we must first compute a gene–level statistic gj that quantifies the magni-
tude of j’s association with the outcome of interest. We then quantify the “decay of differential
expression” with the Kendall τB rank correlation coefficient between the differential expression and
distance from gene i.
The observed discordance is
Di(r) = τB ({gj : dij≤r}, {dij : dij≤r}) , (2)
where dij is the geodesic distance between gene j and gene i.
To assess the statistical significance of Di(r), we randomly permute the phenotype labels and
recompute the gene–level association statistics gj under the null hypothesis that the genes are
not meaningfully associated with the phenotype. We then use the permuted g∗j to recompute D
∗
i
according to Equation 2. A set of 103 such re-computations forms a reference distribution against
which we compare the observed Di to obtain a p value p
D
i (r) as the fraction of D
∗
i < Di.
It should be noted here that while pSi (r) (above) was obtained by randomly permuting genes,
pDi (r) is obtained by permuting the class labels. An important feature of the latter is that it pre-
serves correlations between genes that were found in the pSi (r) calculation. In consequence, the null
models, and hence the interpretations, of the two tests differ. pSi (r) quantifies whether the neigh-
borhood surrounding gene i is more strongly correlated with it than a random set of genes would be
(independent of phenotype), testing the so–called “competitive null” [3]. In contrast, pDi (r) assesses
whether the neighborhood surrounding gene i is more strongly associated with the phenotype of
interest than those same genes would be with randomly–assigned phenotype labels (preserving the
organization of genes in the network), thus testing the so–called “self-contained null” [3]. That
is, it tests whether a specific set of genes in a neighborhood is more strongly associated with the
phenotype of interest than the same set of genes would be for a random phenotype.
Because these two procedures permute orthogonal axes (genes vs. samples), they provide two
independent tests with independent interpretations: pSi (r) tests whether gene i influences its neigh-
bors, and pDi (r) tests whether that neighborhood is associated with disease. We then combine these
independent pieces of evidence into a single assessment, as described below.
Combined Evidence
At this point in our algorithm, the Sphere of Influence and Decay of Differential Expression pro-
cedures have been run independently of each other, but neither component is sufficient by itself to
determine if putative disease gene i is in fact a “disruptive” candidate disease gene meeting both
criteria. Therefore, the last step our method performs is to combine the p-values outputted by each
component (pSi (r) and p
D
i (r)) using Fisher’s method [20],
X2 = −2(ln(pSi (r)) + ln(pDi (r))) . (3)
X2 follows a χ2 distribution with 4 degrees of freedom, which can be used compute pCombi (r), the
combined evidence that gene i is a “disruptive” gene.
Neighborhood Size
Above we described the Sphere of Influence and Decay of Differential Expression procedures for a
fixed radius (r), but different genes may have different extents of influence on the network, and
this extent is not known a priori. Therefore, we have devised our analysis technique to apply the
Sphere of Influence, Decay of Differential Expression, and Combined Evidence calculations to the
neighborhood of every radius (up to D the diameter of the network). The p-value our method
outputs for each gene (pGSi ), therefore, is the smallest p
Comb
i (r) across all distances.
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To evaluate the significance of pGSi , we then apply a Bonferroni correction to the significance
threshold to conservatively adjust for the multiple hypothesis tests that we perform when applying
our method to the neighborhoods of each radius. Since the number of neighborhoods (and therefore
number of tests) is determined by the diameter of the network, we scale the significance threshold by
the diameter of the network to determine whether a gene was significantly found to be “disruptive”
in the data. Adjustment for the multiplicity of genes tested is achieved through permutation as
previously described [21, 22, 6]; this has the important benefit of preserving the biologically-relevant
dependency structure between genes [22, 6].
Example of GeneSurrounder steps applied to an example gene
To illustrate the components of the GeneSurrounder computation, we present the results for each
component of our algorithm as applied to gene MCM2 using data from one study of high-vs-low
grade ovarian cancer [23] (GEO accession GSE14764). In Figure 4, each of the first three plots (from
top to bottom) displays the − log10(p) from the Sphere of Influence, Decay of Differential Expression
and Combined components of our method. Since we compute these values as a function of network
neighborhood size surrounding that gene, the p-values are plotted against the neighborhood radius
(i.e. radius of geodesic distance from the putative “disruptive” disease disease gene MCM2.)
Figure 4A (Sphere of Influence) illustrates the dilution of influence with distance and the effect
that the size (i.e. number of assayed genes) of a neighborhood has on the decrease of influence. The
putative disease gene in this example, MCM2, has significant influence in neighborhoods near to
it, but this influence falls off and stays non-significant at far-away distances. The largest difference
occurs between a radius of 5 and 6, where the number of assayed genes within the neighborhood
(Figure 4D) increases sharply, contributing to the dilution of MCM2 ’s influence.
Figure 4B (Decay of Differential Expression) indicates a significant concentration of differential
expression for neighborhoods with radii of 4–6. We observe that small neighborhoods immediately
near a putative disease gene are not big enough to detect a decaying pattern of differential expres-
sion, such that the localized differential expression is only detectable at with a radius of at least 4.
At the other end, big neighborhoods are too diverse to exhibit a consistent decay of differential ex-
pression; like the sphere of influence, the significance of the decay of differential expression flattens
out at large distances.
Figure 4C illustrates the results of combining the results for each neighborhood. The p-value
our method outputs for each gene is the most significant pCombi (r) across all neighborhood radii;
for MCM2 in this study, this occurs at a neighborhood radius of 4 with pGS = 1.48e−05. Since
our method returns the smallest pCombi (r) for each gene (equivalently, the largest − log10 pCombi (r))
and the smallest pCombi (r) of MCM2 is highly significant, MCM2 would be identified as a central
candidate disease gene of high grade ovarian cancer. From a biological standpoint, this finding is
sensible: MCM2 is a DNA replication factor, and therefore likely plays a role in the aggressive
proliferation associated with high-grade ovarian carcinoma.
3 Results
Application to Ovarian Cancer Data with Global KEGG Network Model
We apply our algorithm to three gene expression data sets of high-vs-low grade ovarian cancer from
the publicly available and curated collection ‘curatedOvarianData’ [23] to illustrate the components
of the GeneSurrounder method and evaluate its performance. In order to test our algorithm, we
evaluate its cross-study concordance, i.e., its consistency across different data sets that are measur-
ing the same conditions, as previously described [4]. The intuition underlying this approach is that
methods that detect true biological signals should find them across different data sets measuring
the same conditions. To test this, we use data from three independent studies of gene expression
of 7680 genes (common in all three studies) in patients with high and low grade cancer (Table 1).
The data was downloaded using the Bioconductor package ‘curatedOvarianData’ [23]. The curate-
dOvarianData project was designed to facilitate meta-analysis and therefore provides data that
has been harmonized to ensure that clinical data (such as grade) are comparable across studies.
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Gene expression data was preprocessed by the original authors using established normalization
techniques, and no further preprocessing was required
Our method combines two independent sources of information — the gene expression data and
a pathway network model — to detect the disruptive genes of the phenotype under consideration.
We use the same global network model for each study, which we have constructed from KEGG
pathways [5]. The KEGG database organizes experimentally derived pathway information into
individual networks of functionally related molecules. In the KEGG representation, the nodes (i.e.
vertices) are genes or gene products, and the links (i.e. edges) are cellular interactions. We create a
global KEGG network to avoid the artificial boundaries between individual pathways by taking the
graph union of the individual pathways, i.e. merging the pathways so that the links which are in
at least one KEGG pathway will be part of the new global network. We then consider the largest
connected component of the resulting network in our algorithm. This global network has N = 4867
nodes, L = 42874 edges, and a diameter D = 34. Of the N = 4867 nodes, 2709 of them are also
amongst the 7680 genes assayed in all three ovarian cancer studies.
We apply our method to each of the ovarian cancer studies with the global gene network to
calculate the combined evidence pCombi (r) for each of the 2709 genes i that are assayed and on
the network. A table of the full results is provided as an additional file [see Additional file 1,
Additional file 2, Additional file 3]. With the results from each of the three ovarian cancer data
sets, we evaluate not only the cross-study concordance of our analysis technique, but also its ability
to identify biologically relevant genes and truly integrate pathway and expression data.
Disruptive genes found by GeneSurrounder are associated with ovarian
cancer
To evaluate GeneSurrounder’s ability to identify biologically relevant genes, we compare our results
in all three ovarian cancer studies (Table 2) to existing biological knowledge. Applying GeneS-
urrounder to the 2709 common genes between studies that were assayed and on the network, we
generated three distinct ranked lists of genes for each study based on the computed pGSi value. To
compare these results to existing biological knowledge, we consider genes that pass our Bonferroni
corrected threshold (at significance level α = 0.05 and with a diameter of D = 34, our Bonferroni
corrected threshold is − log10(p) ≥ 2.83) in all three studies (Table 2).
We used the DOSE R package [24] to analyze the enrichment of these genes with Disease
Ontology (DO) terms [25]. We found that the genes that pass our Bonferroni corrected threshold
in at least one ovarian cancer study were significantly enriched with the DO term “ovarian cancer”
(DOID:2394) (p = 0.0000177). Furthermore, amongst these genes are three families of protein
coding genes, CDC (involved in the cell division cycle), MCM, and ORC (both involved in DNA
replication), with biological functions that support their role in ovarian cancer.
To further compare our results to existing biological knowledge, we found evidence in the liter-
ature that CDC7, ORC6L, and DBF4 are associated specifically with ovarian cancer [26, 27, 28].
The inclusion of CDC45 suggests the possibility that it is also associated with ovarian cancer.
CDC7 encodes for a cell division cycle protein and has been found to both predict survival and be
a powerful anticancer target in ovarian cancer [26]. ORC6L encodes for a origin recognition com-
plex that is crucial for the initiation of DNA replication and has been found to highly expressed in
ovarian cancer [27]. DBF4 encodes for a protein that activates the kinase activity of CDC7 and
was found to be associated with ovarian cancer [28]. The finding of these genes from studies of
high-vs-low grade ovarian cancers suggests the possibility that they are not only involved in ovarian
cancer but, more specifically, drive high grade ovarian cancer. A table of the full results is provided
as an additional file [see Additional file 1, Additional file 2, Additional file 3].
GeneSurrounder results represent a true integration of pathway and ex-
pression data
The method that we have developed combines gene expression data with an independent network
model. To investigate whether our results are driven solely by either the network or the expression
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data or represent a true integration of biological knowledge (the pathway networks) and experi-
mental data, we consider the association between our results, the centrality, and the differential
expression for each gene. If the results were driven solely by the network, the evidence a gene is
a disruptive gene would correlate strongly with its centrality in the network. We therefore cal-
culate the correlation between our results and two different measures of centrality. If the results
were driven solely by the expression data, the evidence a gene is a disruptive gene would correlate
strongly with its differential expression We therefore calculate the correlation between our results
and the differential expression for each of the studies. The results are given in Table 3. We find that
for each of the studies, the correlations are small (on the order of 0.01), confirming that GeneS-
urrounder is not driven solely by network features or the expression data, but rather represents a
true integration of biological knowledge (the pathway networks) with experimental data.
GeneSurrounder findings are more concordant than differential expression
analysis
The intuition underlying evaluating cross-study concordance is that methods that detect true bio-
logical signals should find them across different data sets measuring the same conditions. To investi-
gate the cross-study concordance of our analysis technique (i.e. its consistency across different data
sets measuring the same conditions), we consider each pair of the three studies and calculate the
correlation between our results. As a point of reference, we also calculate the correlation between
the gene level statistics obtained using the customary t-test for differential expression. The results
are given in Table 4. As mentioned earlier, methods that do not take into account systems-level
information tend to have poor agreement between studies because the individual genes contributing
to disease-associated mechanisms can vary from one study to the next. Indeed, we find that the
cross-study concordance of differential expression results is remarkably low (Table 4). By contrast
our method is 3.51—8.55 times more consistent than differential expression analysis. This cross–
study concordance suggests that our method reliably detects biological effects reproducibly across
studies.
GeneSurrounder findings are more concordant than LEAN
We also compare GeneSurrounder to LEAN, a recent method that also attempts to integrate gene
expression and network data to identify significant genes. In contrast to our method, LEAN con-
siders only the immediate neighborhood (i.e. at a radius of one) and assesses the enrichment of
significant genes. To compare the performance of our analysis technique to LEAN, we compare
their respective cross-study concordances. To ensure comparability between our method and LEAN,
we use the same network and expression data for inputs to LEAN that we used for GeneSurrounder.
Again, we consider each pair of the three studies and calculate the correlation between our results
and the correlation between results of LEAN [19] (which is available as an R package on CRAN).
The results are given in Table 4. We found that while LEAN is more consistent than the dif-
ferential expression analysis, GeneSurrounder is more consistent than LEAN. That is, the list of
“disruptive” genes detected by GeneSurrounder are more reproducible across studies than both
differentially expressed genes and the results from LEAN.
Application to Bladder Cancer Data with Global KEGG Network Model
As a further demonstration of our method, we apply our algorithm to three gene expression data
sets of superficial-vs-invasive bladder cancer from the publicly available and curated collection
‘curatedBladderData’ [29]. As in our application to ovarian cancer, the bladder cancer data was
downloaded using the Bioconductor package ‘curatedBladderData’ and we did not do any additional
pre-processing to the bladder cancer datasets used in this study. The same global KEGG network
we created to analyze the Ovarian Cancer Data was used to analyze the Bladder Cancer Data. Of
the N = 4867 genes in our global KEGG network, 3406 of them were common to all three bladder
cancer studies (Table S1) and could be mapped to KEGG IDs using the org.HS.eg.db package [30].
We apply our method to each of the the 3406 genes that were in the microarray data and on the
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network for each bladder cancer study and evaluate the cross study concordance in these additional
datasets, as well as GeneSurrounder’s ability to identify known bladder cancer-associated genes.
A table of the full results is provided as an additional file [see Additional file 4, Additional file 5,
Additional file 6].
We find that while the results of our method (pGS) for GSE13507 and GSE32894 are similar
to their expected theoretical distributions (the minimum of N = 34 independent U(0, 1) random
variables) the results for GSE31684 do not. We expect that this is due to the comparatively low
sample size of GSE31684, which had only 15 samples in the ”superficial” classification. As a result,
when finding genes that pass our Bonferroni corrected threshold (at a threshold of p = 0.05 and
with a diameter of D = 34, our Bonferroni corrected threshold is − log10(p) ≥ 2.83) none of the
genes in GSE31684 pass this threshold. However, we do find genes that pass this threshold in both
GSE13507 and GSE32894 (Table S2). We also confirm that GeneSurrounder is not driven solely by
network features or the bladder cancer expression data (Table S3). While all concordance values for
all methods were generally lower in the bladder cancer studies than in the ovarian cancer studies,
we nevertheless find that GeneSurrounder is still more concordant than both differential expression
analysis and LEAN (Table S4). Complete results of the bladder cancer data analysis, including
discussion of significant genes, is provided in a Supplementary file [See Additional file 7].
4 Discussion
In this manuscript, we have developed and presented a new analysis technique, GeneSurrounder,
that integrates a network model with expression data to identify individual genes that can be
targeted therapeutically. Our analysis technique identifies “disruptive” genes — genes that impact
pathway networks in a disease associated manner. The algorithm consists of two tests that are run
independently of each other and then combined. The first test, Sphere of Influence, calculates the
evidence that a putative disease gene is correlated with its neighbors, and the second test, Decay
of Differential Expression, calculates the evidence that the neighbors of a putative disease gene are
differentially expressed (with the magnitude of differential expression decreasing with distance).
We applied our algorithm to three gene expression data sets of high-vs-low grade ovarian can-
cer [23] and combined each of them with the same global network model that we constructed from
KEGG pathways. With the results from each of the three ovarian cancer data sets, we evaluated
our analysis technique. By applying our method to three different data sets measuring the same
conditions, we were able to show that it yields consistent (i.e. concordant) results across studies,
suggesting its ability to detect biologically meaningful associations that are reproducible across
studies. We also compare our results to existing biological knowledge and find that our method
identifies biologically relevant genes. To show that our method truly integrates pathway and ex-
pression data, we compare the results from our method to the results from a single gene analysis
and the centrality of the genes in the network. Our positive results along these three dimensions
of our analysis technique suggest that our method is a promising new strategy for identifying the
genes that control disease.
As discussed in the Introduction, pathway analysis techniques such as GSEA [6], jActiveMod-
ules [10], and COSINE [12] use interaction networks and expression data to find groups of related
disease-associated genes. GeneSurrounder, to make experimental follow-up easier, identifies precise
gene targets rather than groups of tens or hundreds of genes. Efforts to identify individual genes,
as our method does, have either required prior biological knowledge (as in ENDEAVOUR [14] and
GeneWanderer [15]) or have not used direct interactions on a global network (as in [16], an exten-
sion of SPIA [17], and nDGE [18]). Our analysis technique addresses these shortcomings by using
the shortest direct distance on a global network and not requiring any prior biological knowledge.
LEAN [19] considers interactions on a global interaction network and is closest to our method in
this respect, but restricts its focus to nearest neighbors on the network and does not determine
whether a putative disease gene is the source of change on the network.
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5 Conclusions
The key innovation of GeneSurrounder is the combination of pathway network information with gene
expression data to determine the degree to which a gene is a source of dysregulation on the network.
GeneSurrounder employs a novel strategy by finding genes that both appear to influence nearby
genes and cause dysregulation associated with the disease. Because GeneSurrounder considers every
neighborhood size around a putative gene, it is able to identify disease genes that may have broad
effects on the regulatory network (beyond nearest neighbors). GeneSurrounder thus provides a
new avenue for identifying disease-associated genes by detecting genes that appear to be sources of
change and could therefore be promising therapeutic targets.
While our method performs well in practice, there are limitations that bear consideration. We
note that the the network model that we use, KEGG, is not phenotype-specific (as are most pathway
databases) and we therefore have to assume that the network does not change between conditions.
Additionally, because KEGG (and other pathway databases) may not be complete, genes which are
not known to play a role any pathway cannot be considered in a GeneSurrounder analysis. Further-
more, as implemented our algorithm calculates geodesic distances between genes without taking
into account the direction or type of interactions. However, we note that our approach as presented
here could easily be modified to take in as input other kinds of networks (including context-specific
computationally derived networks) and/or considering edge directionality by changing the gene-
gene distance matrix that the Sphere of Influence and Decay of Differential computations use.
GeneSurrounder can be potentially generalized to other types of data. For instance, one might
envision applying it to other kinds of omic data. For example, GeneSurrounder could potentially
be extended to use genomic sequence data to identify epistatic interactions, evidenced by gene
neighborhoods that have a high level of correlations in their genetic variants. Our method could
also possibly be generalized for time-series gene expression data by either changing the gene-level
statistics used by the algorithm or applying it separately to time points.
GeneSurrounder thus provides means to prioritize genes that are sources of disruption for a
disease in the context of gene regulatory networks. By prioritizing genes in this way, our method
provides insights into disease mechanisms and suggests diagnostic and therapeutic targets. Our
method can be used to help biologists select among tens or hundreds of genes for further validation.
Furthermore, it can be generalized to other kinds of networks (including context-specific networks)
and omic data. This approach can not only be used directly to prioritize promising targets, but
also suggests new strategies for integrating systems level information with omic data to identify,
validate, and target disease mechanisms. We have made the implementation of our method available
to researchers on GitHub at http://github.com/sahildshah1/gene-surrounder with the
aim of furthering our understanding of statistical techniques to identify disease-associated genes.
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Tables
GEO Accession No. N(low-grade) N(high-grade)
GSE14764 24 44
GSE17260 67 43
GSE9891 103 154
Table 1: Ovarian cancer datasets used in this study: Comparisons were made between low– and
high–grade serous ovarian carcinoma using public data. Sample sizes for each group in each dataset are
given. The data are publicly accessible and available as part of the curatedOvarianData package [23].
− log10 pGS
Gene GSE14764 GSE17260 GSE9891
ADRB3 3.033 2.933 3.554
AURKA 2.865 3.383 3.716
CDC45 4.270 3.741 4.830
CDC7 4.386 3.769 4.830
DBF4 4.270 3.769 4.830
IL7 3.055 2.898 2.910
ITGAM 2.961 3.024 3.094
MCM2 4.830 3.372 4.830
MCM3 4.830 3.383 4.830
MCM4 4.830 3.394 4.830
MCM5 4.830 3.372 4.830
MCM6 4.830 3.428 4.830
ORC4 4.386 3.172 4.830
ORC6 4.386 3.691 4.830
TTK 2.904 3.089 4.830
Table 2: “Disruptive” disease genes in high-grade ovarian cancer consistently found by
GeneSurrounder: At a threshold of p = 0.05 and with a diameter of D = 34, the Bonferroni
corrected threshold is − log10(p) ≥ 2.83. Listed are the genes that pass this threshold in all three
studies.
Network/Gene Statistic GSE14764 GSE17260 GSE9891
Degree Cor. 0.044 0.070 0.038
Betweenness Cor. 0.047 0.059 0.030
pDE Cor. 0.060 0.103 −0.051
Table 3: Correlation between GeneSurrounder results and network/gene statistics: The
three columns are the rank correlation between GeneSurrounder results (pGS) and network/gene statis-
tics (Degree, Betweenness, and pDE) across all genes in each dataset. The Degree and Betweenness
are two different network centrality measures. The Degree is the number of connections a node has
and the Betweenness is the fraction of shortest paths that passes through the node. pDE is the p-value
obtained from a standard differential expression t-test.
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Ovarian Cancer Study Pair pGS Cor. pDE Cor. pLEAN Cor.
GSE14764 - GSE17260 0.342 0.040 0.056
GSE14764 - GSE9891 0.436 0.056 0.130
GSE17260 - GSE9891 0.485 0.138 0.290
Table 4: Cross study concordance of GeneSurrounder results compared to differential
expression analysis and LEAN: The columns pGS Cor., pDE Cor., and pLEAN Cor. are the Spear-
man rank correlations respectively between the results obtained from GeneSurrounder, differential
expression analysis, and LEAN for each study pair.
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Figure 1: Overview of GeneSurrounder algorithm. The algorithm incorporates systems–level
information, in the form of a network model of cellular interactions, with gene expression data to iden-
tify the genes that control disease–associated mechanisms. The algorithm than identifies “disruptive”
genes by assessing the significance of the combined evidence that (1) a gene has a influence on others
in the network and (2) that its influence is driving disease.
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Figure 2: Procedure for Sphere of Influence. The Sphere of Influence computation tests if a
putative driver gene is more correlated with its neighbors than a random sample of genes.
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Figure 3: Procedure for Decay of Differential Expression. The Decay of Differential Expression
computation tests if the discordance between differential expression and distance from the driver gene
is greater with the phenotype labels we observe than with a random permutation of the sample labels.
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Figure 4: Illustration of Method. Displayed are the results for the gene MCM2 when our algorithm
was applied to Ovarian Cancer Study GSE14764. (a) shows − log10(pSphere) vs the Neighborhood
Radius. (b) shows − log10(pDecay) vs the Neighborhood Radius. (c) shows − log10(pCombined) vs the
Neighborhood Radius. (d) shows the Number of Assayed Genes vs the Neighborhood Radius. In
the top three plots, the dashed and dotted lines correspond to a significance level of 0.05 and 0.01
respectively. In the bottom plot, the solid line corresponds to the total number of genes assayed and
on the network. 16
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Supplement
GeneSurrounder Analysis of curatedBladderData
In this supplement, we detail the results of applying GeneSurrounder to data from the curated-
BladderData package. The analysis parallels that of the ovarian cancer data described in the main
manusript.
Disruptive genes found by GeneSurrounder are associated with bladder
cancer
To evaluate GeneSurrounder’s ability to identify biologically relevant genes, we compare our results
in all three bladder cancer studies (Table S2) to existing biological knowledge. Applying GeneS-
urrounder to the 3406 common genes between studies that were assayed and on the network, we
generated three distinct ranked lists of genes for each study based on the computed pGSi value. To
compare these results to existing biological knowledge, we consider genes that pass our Bonferroni
corrected threshold (at significance level α = 0.05 and with a diameter of D = 34, our Bonferroni
corrected threshold is log10(p) ≥ 2.83) in all three studies (Table S2).
We used the DOSE R package [24] to analyze the enrichment of these genes with Disease
Ontology (DO) terms [25]. We found that the genes that pass our Bonferroni corrected threshold
in at least one bladder cancer were significantly enriched with the DO term “bladder cancer”
(DOID:11054) (p = 0.00280). Furthermore, our method found DUSP1 and TNFRSF13B. DUSP1
plays an important role in the negative regulation of cellular proliferation and can make some solid
tumors resistant to therapy. TNFRSF13B belongs to the tumor necrosis factor (TNF) ligand family
and plays roles in events such as cell survival, proliferation, differentiation, and death. The finding
of these genes from studies of superficial-vs-invasive bladder is sensible and suggests that they may
not only be involved in cancer, but, more specifically, superficial-vs-invasive bladder cancer. A table
of the full results is provided as an additional file [see Additional file 4, Additional file 5, Additional
file 6].
GeneSurrounder results represent a true integration of pathway and ex-
pression data
The method that we have developed combines gene expression data with an independent network
model. To investigate whether our results are driven solely by either the network or the expression
data or represent a true integration of biological knowledge (the pathway networks) and experi-
mental data, we consider the association between our results, the centrality, and the differential
expression for each gene. If the results were driven solely by the network, the evidence a gene is
a disruptive gene would correlate strongly with its centrality in the network. We therefore cal-
culate the correlation between our results and two different measures of centrality. If the results
were driven solely by the expression data, the evidence a gene is a disruptive gene would correlate
strongly with its differential expression We therefore calculate the correlation between our results
and the differential expression for each of the studies. The results are given in Table S3. We find
that for each of the studies, the correlations are small (at most +0.194), confirming that GeneS-
urrounder is not driven solely by network features or the expression data, but rather represents a
true integration of biological knowledge (the pathway networks) with experimental data.
GeneSurrounder findings are more concordant than differential expression
analysis
The intuition underlying evaluating cross-study concordance is that methods that detect true bi-
ological signals should find them across different data sets measuring the same conditions. To
investigate the cross-study concordance of our analysis technique (i.e. its consistency across dif-
ferent data sets measuring the same conditions), we consider each pair of the three studies and
calculate the correlation between our results. As a point of reference, we also calculate the correla-
tion between the gene level statistics obtained using the customary t-test for differential expression.
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The results are given in Table S4. As mentioned earlier, methods that do not take into account
systems-level information tend to have poor agreement between studies because the individual genes
contributing to disease-associated mechanisms can vary from one study to the next. Indeed, we
find that the cross-study concordance of differential expression results is remarkably low (Table S4).
By contrast our method is more consistent than differential expression analysis. This cross–study
concordance suggests that our method reliably detects biological effects reproducibly across studies.
GeneSurrounder findings are more concordant than LEAN
We also compare GeneSurrounder to LEAN, a recent method that also attempts to integrate gene
expression and network data to identify significant genes. In contrast to our method, LEAN con-
siders only the immediate neighborhood (i.e. at a radius of one) and assesses the enrichment of
significant genes. To compare the performance of our analysis technique to LEAN, we compare
their respective cross-study concordances. To ensure comparability between our method and LEAN,
we use the same network and expression data for inputs to LEAN that we used for GeneSurrounder.
Again, we consider each pair of the three studies and calculate the correlation between our results
and the correlation between results of LEAN [19] (which is available as an R package on CRAN).
The results are given in Table S4. We found that GeneSurrounder is more consistent than LEAN.
That is, the list of “disruptive” genes detected by GeneSurrounder are more reproducible across
studies than both differentially expressed genes and the results from LEAN.
Tables
GEO Accession No. N(superficial) N(invasive)
GSE13507 103 62
GSE31684 15 78
GSE32894 213 93
Table S1: Bladder cancer datasets used in this study: Comparisons were made between super-
ficial and invasive bladder cancer using public data. Superficial bladder cancer has not grown into the
main muscle layer of the bladder and invasive bladder cancer has grown into the main muscle layer of
the bladder. Sample sizes for each group in each dataset are given. The data are publicly accessible
and available as part of the curatedBladderData package [29].
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− log10 pGS
Gene GSE13507 GSE31684 GSE32894
A2M 3.046 0.799 2.987
ABLIM2 3.992 0.415 4.107
CCL11 3.523 0.123 3.104
CCL19 4.107 0.121 2.980
CD14 4.046 0.281 3.416
CD209 3.296 0.229 2.895
CD22 3.452 0.166 3.016
CD226 3.383 0.257 2.950
CD247 3.479 0.195 3.041
CD3G 2.901 0.289 2.904
CD48 2.868 0.484 3.716
CSF2 4.830 0.028 3.416
CTSG 3.280 0.008 2.841
DOCK2 2.859 0.170 2.991
DUSP1 4.830 0.076 3.248
DUSP5 3.523 0.080 3.280
FYB 2.901 0.214 3.149
GRAP2 3.079 0.280 3.234
GZMA 3.903 0.210 2.901
IL18RAP 2.865 0.103 3.372
IL1A 3.120 0.107 2.991
IL1B 2.860 0.131 3.314
IL6 3.830 0.029 3.493
IQGAP2 2.995 0.284 3.691
IRF1 4.180 0.067 2.907
IRF8 3.428 0.960 3.264
ITGAM 4.046 0.412 3.173
JUN 2.947 0.134 2.991
LCP2 4.270 0.031 2.889
LIF 2.848 0.130 3.405
MAP3K8 3.669 0.107 3.342
MAP4K1 4.270 0.481 3.115
MEF2C 3.199 0.165 2.897
MSN 4.830 0.408 2.904
NCKAP1L 4.045 0.337 3.865
NKD1 3.669 0.100 3.830
NLRP3 3.522 0.120 2.901
NTF3 3.248 0.069 2.910
OSM 3.493 0.124 3.003
PDCD1LG2 3.865 0.112 2.995
PLAU 4.181 0.173 3.154
POMC 3.079 0.055 2.999
PTPN7 3.241 0.078 2.991
RAC2 3.160 1.008 3.589
RELB 4.829 0.422 4.386
RUNX1T1 3.234 0.118 2.987
SEC23B 3.104 2.102 3.041
SELP 4.830 0.153 3.226
SERPINA1 3.523 0.663 3.256
SERPING1 4.181 0.285 3.248
SH2D1A 3.992 0.245 3.992
SIRPG 3.323 0.027 2.857
SLIT2 3.945 0.125 3.185
TCL1A 2.954 0.458 3.093
THY1 3.296 0.080 2.910
TNFAIP3 3.016 0.213 3.305
TNFRSF13B 4.180 0.256 4.386
TNFSF13B 2.991 0.255 4.108
TYROBP 3.120 0.392 2.914
WAS 4.830 0.328 3.173
ZAP70 4.830 0.149 3.205
ZBP1 3.768 0.293 4.549
Table S2: “Disruptive” disease genes in bladder cancer consistently found by GeneSur-
rounder: At a threshold of p = 0.05 and with a diameter ofD = 34, the Bonferroni corrected threshold
is − log10(p) ≥ 2.83. Listed are the genes that pass this threshold in GSE13507 and GSE32894.
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Network/Gene Statistic GSE13507 GSE31684 GSE32894
Degree Cor. +0.084 +0.194 +0.120
Betweenness Cor. +0.063 +0.084 +0.058
pDE Cor. +0.107 +0.111 −0.016
Table S3: Correlation between GeneSurrounder results and network/gene statistics: The
three columns are the rank correlation between GeneSurrounder results (pGS) and network/gene statis-
tics (Degree, Betweenness, and pDE) across all genes in each dataset. The Degree and Betweenness
are two different network centrality measures. The Degree is the number of connections a node has
and the Betweenness is the fraction of shortest paths that passes through the node. pDE is the p-value
obtained from a standard differential expression t-test.
Bladder Cancer Study Pair pGS Cor. pDE Cor. pLEAN Cor.
GSE13507 - GSE31684 +0.033 +0.008 −0.086
GSE13507 - GSE32894 +0.317 −0.045 −0.020
GSE31684 - GSE32894 +0.119 +0.010 −0.005
Table S4: Cross study concordance of GeneSurrounder results compared to differential
expression analysis and LEAN: The columns pGS Cor., pDE Cor., and pLEAN Cor. are the Spear-
man rank correlations respectively between the results obtained from GeneSurrounder, differential
expression analysis, and LEAN for each study pair.
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